
Supporting Self-isolation for COVID-19 With “Risk Mitigation” Prescribing and Housing Supports for People Who Use Drugs: A Case Report
Author(s) -
Ran Ha Hong,
Rupinder Brar,
Nadia Fairbairn
Publication year - 2022
Publication title -
journal of addiction medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.264
H-Index - 42
eISSN - 1935-3227
pISSN - 1932-0620
DOI - 10.1097/adm.0000000000000954
Subject(s) - medicine , polysubstance dependence , isolation (microbiology) , pandemic , outreach , harm reduction , covid-19 , drug , environmental health , medical emergency , public health , substance abuse , psychiatry , nursing , disease , infectious disease (medical specialty) , economic growth , pathology , microbiology and biotechnology , economics , biology
Self-isolation is critical in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. However, people who use drugs face significant barriers in adhering to the regulations. As a response, several supportive measures have been introduced in British Columbia, including temporary housing access and "risk mitigation" prescribing, in which health care providers prescribe pharmaceutical alternatives to the unregulated drug supply to prevent withdrawal and reduce overdose risk.